Wu and Hu
obtained mixed anhydride solution was slowly added into the
prepared LiAlHSeH solution via cannulation over a period of
5 min. The reaction mixture was stirred for an additional 30 min
below 5 °C under a nitrogen atmosphere. Then, a solution of azide
(1.0 mmol) in THF (1 mL) was added into the above selenocar-
boxylate solution via a syringe. For electron-deficient azides, the
amidation reaction was carried out at 0 °C to room temperature.
For electron-rich azides, 0.5 mmol of the azide was used and the
reaction was carried out at 55 °C. When TLC and/or LC-MS
showed the disappearance of the starting azide or no further change
of the reaction mixture, the reaction mixture was filtered through
a Celite pad that was then rinsed with EtOAc (3 × 25 mL). The
combined organic phase was washed with 5% NaHCO3, water, and
brine and dried over anhydrous Na2SO4. After removal of Na2SO4
through filtration, the filtrate was treated with activated charcoal.
The activated charcoal was filtered off, and the filtrate was then
concentrated to dryness. The crude product was purified by flash
column chromatography (FCC) on silica gel. Yields and physical
and spectroscopic data of all amides are consistent with their
structures.
MHz): δ 10.05 (brs, 1H, -NH), 7.38-7.52 (m, 4H), 4.50 (brs,
-NH), 3.41-3.53 (m, 2H), 1.91-2.28 (m, 4H), 1.49 (s, 9H). 13C
NMR (CDCl3, 50 MHz): δ 171.2, 156.3, 142.6, 133.0, 119.4, 119.0,
106.3, 81.2, 60.7, 47.4, 28.5, 28.3, 24.6. MS (ESI+): m/z (intensity),
316.2 (MH+, 40%), 334.2 (MH+ + H2O, 100%).
NR-tert-Butyloxycarbonyl-N′-(4-cyanophenyl)-L-valinamide (16).
The product (282 mg) was obtained after FCC (CH2Cl2/MeOH,
50:1) in 89% isolated yield. 1H NMR (CDCl3, 200 MHz): δ 9.35
(brs, 1H, -NH), 7.39-7.52 (m, 4H), 5.40 (d, -NH), 4.09-4.16
(m, 1H), 2.06-2.16 (m, 1H), 1.43 (s, 9H), 1.01 (d, 6H, J ) 7.0
Hz). 13C NMR (CDCl3, 50 MHz): δ 171.5, 156.8, 142.0, 133.0,
119.5, 118.9, 106.9, 80.9, 61.2, 30.8, 28.4, 19.6, 18.5. MS (ESI+):
m/z (intensity), 318.2 (MH+, 100%).
NR-(9-Fluorenyloxycarbonyl)-N′-(4-cyanophenyl)-L-glutami-
namide (17). The product (328 mg) was obtained after FCC (CH2-
Cl2/MeOH, 20:1) in 70% isolated yield. 1H NMR (DMSO-d6, 200
MHz): δ 10.54 (s, 1H, -NH), 7.72-7.91 (m, 8H), 7.30-7.46 (m,
4H), 6.83 (s, 1H, -NH), 4.09-4.32 (m, 4H), 2.17-2.21 (m, 2H),
1.83-1.99 (m, 2H). 13C NMR (DMSO-d6, 50 MHz): δ 173.4,
171.7, 156.1, 143.8, 143.1, 140.7, 133.3, 127.7, 127.1, 125.3, 120.1,
119.3, 119.1, 105.1, 65.8, 55.4, 46.6, 31.5, 27.3. MS (ESI+): m/z
(intensity), 469.2 (MH+, 100%), 491.2 (M + Na+, 50%).
NR-Benzyloxycarbonyl-N′-(4-cyanophenyl)-L-phenylalanina-
mide (10). The product (340 mg) was obtained after FCC (CH2-
1
Cl2/MeOH, 10:1) in 85% isolated yield. H NMR (CDCl3, 200
NR-(9-Fluorenyloxycarbonyl)-N′-(4-cyanophenyl)-L-tryptopha-
namide (18). The product (458 mg) was obtained after FCC
MHz): δ 8.80 (brs, 1H, -NH), 7.16-7.48 (m, 14H), 5.82 (d, -NH,
J ) 8.0 Hz), 5.07 (s, 2H), 4.66 (q, 1H, J ) 8.0 Hz), 3.13 (dd, 2H,
J ) 6.6 Hz, J ) 7.4 Hz). 13C NMR (CDCl3, 50 MHz): δ 170.2,
156.7, 141.5, 136.0, 135.8, 133.2, 129.3, 129.0, 128.7, 128.5, 128.1,
127.9, 127.4, 119.8, 107.3, 67.6, 57.4, 38.4. MS (ESI+): m/z
(intensity), 400.2 (MH+, 100%), 441.2 (MH+ + CH3CN, 15%).
O3-Benzyl-NR-benzyloxycarbonyl-N′-(4-cyanophenyl)-L-seri-
namide (11). The product (384 mg) was obtained after FCC (CH2-
1
(hexane/CH2Cl2/MeOH, 10:10:1) in 87% isolated yield. H NMR
(CDCl3, 200 MHz): δ 8.38 (brs, 1H, -NH), 8.10 (s, 1H, NH),
7.78 (d, 2H, J ) 7.4 Hz), 7.28-7.61 (m, 11H), 7.17 (t, 2H, J )
8.0 Hz), 7.05 (t, 2H, J ) 8.0 Hz), 6.95 (brs, 1H, NH), 4.68 (m,
1H), 4.34 (d, 2H, J ) 6.8 Hz), 4.17 (t, 1H, J ) 7.4 Hz), 3.26-3.31
(m, 2H). 13C NMR (CDCl3, 50 MHz): δ 170.4, 156.5, 143.5, 143.4,
141.3, 136.1, 133.0, 127.8, 127.1, 127.0, 124.9, 123.2, 122.5, 120.1,
120.0, 119.7, 118.7, 118.4, 111.4, 109.9, 107.1, 67.4, 56.4, 46.9,
28.2. MS (ESI+): m/z (intensity), 527.2 (MH+, 100%), 549.2 (M
+ Na+, 20%).
1
Cl2/MeOH, 50:1) in 89% isolated yield. H NMR (CDCl3, 200
MHz): δ 8.85 (brs, 1H, -NH), 7.45-7.55 (m, 4H), 7.23-7.32
(m, 10H), 5.92 (d, 1H, J ) 6.8 Hz), 5.11 (s, 2H), 4.47-4.60 (m,
3H), 3.92-3.97 (m, 1H), 3.62-3.70 (m, 1H). 13C NMR (CDCl3,
50 MHz): δ 16.8.7, 156.3, 141.4, 136.9, 135.7, 133.0, 128.5, 128.4,
128.2, 128.1, 127.9, 127.7, 119.6, 118.7, 107.1, 73.5, 69.3, 67.3,
55.0. MS (ESI+): m/z (intensity), 430.2 (MH+, 100%), 452.2 (M
+ Na+, 20%).
NR-tert-Butyloxycarbonyl-L-leucyl-N′-(4-cyanophenyl)-L-tryp-
tophanamide (19). The product (450 mg) was obtained after FCC
1
(CH2Cl2/MeOH, 20:1) in 87% isolated yield. H NMR (CD3OD,
200 MHz): δ 7.59 (d, 2H, J ) 8.4 Hz), δ 7.43-7.50 (m, 3H),
7.21 (d, 1H, J ) 8.0 Hz), 7.01 (s, 1H), 6.85-6.97 (m, 2H), 4.67
(m, 1H), 3.95 (t, 1H), 3.22-3.25 (m, 2H), 1.40-1.60 (m, 1H), 1.35
(t, 2H, J ) 6.6 Hz), 1.25 (s, 9H), 0.80 (dd, 6H, J ) 8.2 Hz). 13C
NMR (CD3OD, 50 MHz): δ 175.7, 172.7, 158.2, 143.8, 138.0,
134.0, 128.7, 124.7, 122.5, 121.2, 119.9, 119.8, 119.3, 112.3, 110.2,
107.8, 80.9, 56.1, 55.1, 41.6, 28.6, 25.8, 23.3, 21.8. MS (ESI+):
m/z (intensity), 540.3 (M + Na+, 100%), 581.3 (M + Na+ + CH3-
CN, 37%).
O3-Acetyl-NR-tert-butyloxycarbonyl-D,L-seryl-N′-(4-cyanophe-
nyl)-L-phenylalaninamide (20). The product (454 mg) was
obtained after FCC (CH2Cl2/MeOH, 20:1) in 92% isolated yield.
1H NMR (CD3OD, 200 MHz): δ 7.68 (d, 2H, J ) 8.4 Hz), 7.55
(d, 2H, J ) 8.4 Hz), 7.14 (brs, 5H), 4.67 (dd, 1H, J ) 8.4 Hz, J )
8.4 Hz), 4.14-4.20 (m, 1H), 4.00-4.09 (m, 2H), 2.88-3.18 (m,
2H), 1.89 (s, 3H), 1.36 (s, 9H). 13C NMR (CD3OD, 50 MHz): δ
172.2, 171.8, 157.6, 143.7, 137.9, 137.7, 134.1, 130.3, 129.5, 127.9,
121.2, 119.7, 107.8, 81.0, 64.7, 56.5, 55.1, 38.9, 28.6, 20.7. MS
(ESI+): m/z (intensity), 517.3 (M + Na+, 100%), 558.2 (M + Na+
+ CH3CN, 40%).
NR-tert-Butyloxycarbonyl-L-asparaginyl-L-leucyl-N′-(4-cy-
anophenyl)-L-tryptophanamide (21). The product (523 mg) was
obtained after FCC (CH2Cl2/MeOH, 20:1) in 83% isolated yield.
1H NMR (CD3OD, 200 MHz): δ 7.78 (d, 2H, J ) 8.8 Hz), 7.52
(d, 3H, J ) 8.8 Hz), 7.34 (d, 1H, J ) 8.8 Hz), 7.05 (s, 1H), 6.85-
7.00 (m, 2H), 4.59-4.68 (m, 1H), 4.30-4.37 (m, 1H), 4.05 (t, 1H,
J ) 7.2 Hz), 3.19-3.4 (m, 2H), 2.48-3.13 (m, 2H), 1.47-1.60
(m, 3H), 1.33 (s, 9H), 0.70 (dd, 6H, J ) 8.8 Hz). 13C NMR (CD3-
OD, 50 MHz): δ 175.0, 174.9, 172.9, 157.5, 144.0, 138.0, 134.0,
128.7, 124.6, 122.4, 121.3, 119.8, 119.3, 112.3, 111.3, 107.8, 80.9,
NR-Benzyloxycarbonyl-N′-(4-cyanophenyl)-L-glutamina-
mide (12). The product (342 mg) was obtained after FCC (CH2-
Cl2/MeOH, 20:1) in 90% isolated yield. 1H NMR (DMSO-d6, 200
MHz): δ 10.55 (s, 1H), 7.70-7.85 (m, 4H), 7.36 (brs, 5H), 6.85
(s, 1H), 5.04 (s, 2H), 4.11-4.20 (m, 1H), 2.15-2.21 (m, 2H), 1.70-
1.99 (m, 2H). 13C NMR (DMSO-d6, 50 MHz): δ 174.2, 172.4,
156.8, 143.9, 137.7, 134.0, 129.1, 128.9, 128.5, 120.1, 119.8, 105.9,
66.3, 56.1, 32.1, 28.0. MS (ESI+): m/z (intensity), 381.2 (MH+,
100%), 444.4 (M + Na+ + CH3CN, 15%).
NR-Benzyloxycarbonyl-N′-(4-cyanophenyl)-L-methionina-
mide (13). The product (337 mg) was obtained after FCC (CH2-
1
Cl2/MeOH, 40:1) in 88% isolated yield. H NMR (CDCl3, 200
MHz): δ 9.02 (brs, 1H, -NH), 7.48-7.61 (m, 4H), 7.35 (brs, 5H),
5.78 (d, J ) 8.0 Hz), 5.14 (s, 2H), 4.51-4.62 (m, 1H), 2.62 (t, 2H,
J ) 6.6 Hz), 1.98-2.26 (m, 5H). 13C NMR (CDCl3, 50 MHz): δ
170.3, 156.9, 141.7, 135.8, 133.3, 128.8, 128.6, 128.1, 119.8, 118.8,
107.4, 67.7, 54.9, 30.9, 30.3, 15.4. MS (ESI+): m/z (intensity), 384.1
(MH+, 100%).
O5-Benzyl-NR-benzyloxycarbonyl-N′-(4-cyanophenyl)-L-glutam-
ic Amide (14). The product (394 mg) was obtained after FCC (CH2-
1
Cl2/MeOH, 50:1) in 90% isolated yield. H NMR (CDCl3, 200
MHz): δ 9.30 (brs, 1H, -NH), 7.51-7.64 (m, 4H), 7.36 (brs, 5H),
5.61 (d, -NH, J ) 6.6 Hz), 5.13 (s, 2H), 4.37-4.40 (m, 1H), 2.45-
2.65 (m, 2H), 1.98-2.29 (m, 2H), 1.49 (s, 9H). 13C NMR (CDCl3,
50 MHz): δ 173.3, 170.7, 156.5, 142.0, 135.6, 133.2, 128.7, 128.5,
128.3, 119.7, 118.9, 107.2, 81.0, 66.9, 54.7, 30.7, 28.4, 27.5. MS
(ESI+): m/z (intensity), 438.2 (MH+, 100%).
NR-tert-Butyloxycarbonyl-N′-(4-cyanophenyl)-L-prolina-
mide (15). The product (285 mg) was obtained after FCC (CH2-
1
Cl2/MeOH, 50:1) in 89% isolated yield. H NMR (CDCl3, 200
772 J. Org. Chem., Vol. 72, No. 3, 2007